title: Identification of fat mass and obesity associated (FTO) protein expression in cardiomyocytes: regulation by leptin and its contribution to leptin-induced hypertrophy.
abstract: The recently-identified fat mass and obesity-associated (FTO) protein is associated with various physiological functions including energy and body weight regulation. Ubiquitously expressed, FTO was identified in heart homogenates although its function is unknown. We studied whether FTO is specifically expressed within the cardiac myocyte and its potential role pertaining to the hypertrophic effect of the adipokine leptin. Most experiments were performed using cultured neonatal rat cardiomyocytes which showed nuclei-specific FTO expression. Leptin significantly increased FTO expression which was associated with myocyte hypertrophy although both events were abrogated by FTO knockdown with siRNA. Administration of a leptin receptor antibody to either normal or obese rats significant reduced myocardial FTO protein expression. Responses in cardiomyocytes were accompanied by JAK2/STAT3 activation whereas JAK2/STAT3 inhibition abolished these effects. Expression of the cut-like homeobox 1(CUX1) transcriptional factor was significantly increased by leptin although this was restricted to the cathepsin L-dependent, proteolytically-derived shorter p110CUX1 isoform whereas the longer p200CUX1 protein was not significantly affected. Cathepsin L expression and activity were both significantly increased by leptin whereas a cathepsin L peptide inhibitor or siRNA specific for CUX1 completely prevented the leptin-induced increase in FTO expression. The cathepsin L peptide inhibitor or siRNA-induced knockdown of either CUX1 or FTO abrogated the hypertrophic response to leptin. Two other pro-hypertrophic factors, endothelin-1 or angiotensin II had no effect on FTO expression and FTO knockdown did not alter the hypertrophic response to either agent. This study demonstrates leptin-induced FTO upregulation in cardiomyocytes via JAK2/STAT3- dependent CUX1 upregulation and suggests an FTO regulatory function of leptin. It also demonstrates for the first time a functional role of FTO in the cardiomyocyte.
authors.affiliation: Department of Physiology and Pharmacology, The University of Western Ontario, London, Ontario, Canada.
authors.forename: Xiaohong Tracey
authors.initials: XT
authors.lastname: Gan
authors.forename: Ganjian
authors.initials: G
authors.lastname: Zhao
authors.forename: Cathy X
authors.initials: CX
authors.lastname: Huang
authors.forename: Adrianna C
authors.initials: AC
authors.lastname: Rowe
authors.forename: Daniel M
authors.initials: DM
authors.lastname: Purdham
authors.forename: Morris
authors.initials: M
authors.lastname: Karmazyn
mesh_terms: D000071516:Alpha-Ketoglutarate-Dependent Dioxygenase FTO; D000818:Animals; D001483:Base Sequence; D015153:Blotting, Western; D056668:Cathepsin L / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000378:metabolism; D005455:Fluorescent Antibody Technique; D053614:Janus Kinase 2 / Q000378:metabolism; D020738:Leptin / Q000502:physiology; D008297:Male; D032383:Myocytes, Cardiac / Q000201:enzymology / Q000378:metabolism*; D011506:Proteins / Q000378:metabolism*; D034741:RNA, Small Interfering; D051381:Rats; D017207:Rats, Sprague-Dawley; D050796:STAT3 Transcription Factor / Q000378:metabolism; D014157:Transcription Factors / Q000378:metabolism; D015854:Up-Regulation / Q000502:physiology
chemical_list: C088424:Cux1 protein, rat; D004268:DNA-Binding Proteins; D020738:Leptin; D011506:Proteins; D034741:RNA, Small Interfering; D050796:STAT3 Transcription Factor; C494088:Stat3 protein, rat; D014157:Transcription Factors; D000071516:Alpha-Ketoglutarate-Dependent Dioxygenase FTO; C529321:FTO protein, rat; C507927:Jak2 protein, rat; D053614:Janus Kinase 2; D056668:Cathepsin L
references.citation: PLoS Genet. 2007 Jul;3(7):e115
references.pmid: 17658951
references.citation: Cell Signal. 2012 Dec;24(12):2283-90
references.pmid: 22917533
references.citation: Circulation. 2004 Apr 6;109(13):1580-9
references.pmid: 15066961
references.citation: Nat Med. 1995 Nov;1(11):1155-61
references.pmid: 7584987
references.citation: Obes Rev. 2008 May;9(3):246-50
references.pmid: 18373508
references.citation: Gene. 2012 Apr 10;497(1):18-26
references.pmid: 22306263
references.citation: Am J Physiol Heart Circ Physiol. 2008 Jul;295(1):H441-6
references.pmid: 18469142
references.citation: J Biol Chem. 2011 Jan 21;286(3):2155-70
references.pmid: 21037323
references.citation: PLoS One. 2010 Jan 19;5(1):e8771
references.pmid: 20098739
references.citation: Am Heart J. 2010 Dec;160(6):1163-9
references.pmid: 21146673
references.citation: Nat Genet. 2007 Jun;39(6):724-6
references.pmid: 17496892
references.citation: Mol Med. 2011 May-Jun;17(5-6):523-32
references.pmid: 21267512
references.citation: Trends Cardiovasc Med. 2007 Aug;17(6):206-11
references.pmid: 17662916
references.citation: Mamm Genome. 1999 Oct;10(10):983-6
references.pmid: 10501967
references.citation: Science. 2007 May 11;316(5826):889-94
references.pmid: 17434869
references.citation: Science. 2007 Nov 30;318(5855):1469-72
references.pmid: 17991826
references.citation: Trends Endocrinol Metab. 2011 Feb;22(2):53-9
references.pmid: 21131211
references.citation: Nature. 2009 Apr 16;458(7240):894-8
references.pmid: 19234441
references.citation: Ann N Y Acad Sci. 2011 Mar;1220:162-71
references.pmid: 21388413
references.citation: PLoS One. 2012;7(7):e41612
references.pmid: 22848545
references.citation: Nat Rev Cardiol. 2010 Jan;7(1):22-9
references.pmid: 19949425
references.citation: Nat Genet. 2010 Dec;42(12):1086-92
references.pmid: 21076408
references.citation: Clin Exp Pharmacol Physiol. 2011 Dec;38(12):905-13
references.pmid: 21957899
references.citation: Cardiovasc Res. 2008 Jul 15;79(2):279-86
references.pmid: 18474523
references.citation: Front Biosci (Landmark Ed). 2011 Jun 01;16:2771-93
references.pmid: 21622208
references.citation: Int J Obes (Lond). 2008 Dec;32 Suppl 7:S8-12
references.pmid: 19136996